Ria Health, a Greenwich, CT-based telehealth provider of evidence-based alcohol use disorder (AUD) treatment, raised an undisclosed amount in funding.
The round was led by Peloton Equity, with participation from existing investors including SV Health Investors, BPEA Private Equity, and SOSV.
The company intends to use the funds to continue scaling its clinical model and payor coverage, accelerate investments in sales and marketing, and enhance its position as a value-add partner in the continuum of AUD care.
Led by CEO Bill Stapleton, Ria Health develops an evidence-based telehealth treatment program that combines medical science, technology, and human compassion to help people rapidly improve their lives. The company currently has contracts with 15 payors and provides care via telehealth across all 50 states.
With this funding round, Michael OâRourke, Partner at Peloton Equity, will join Ria Healthâs Board of Directors. Riaâs Board of Directors includes Carol Vallone, Chair of the Board of Trustees at McLean Hospital; Dr. Martin Rosenzweig, former Chief Medical Officer (Behavioral) at UnitedHealthGroup; Michael Balmuth, Managing Partner at SV; Dr. John Mendelson, founder and Chief Medical Officer of Ria; and Bill Stapleton, CEO of Ria.
FinSMEs
06/03/2025